Factbox-Global drugmakers rush to boost US presence as tariff threat looms
PositiveFinancial Markets

In response to looming tariff threats, global drugmakers are rapidly increasing their presence in the U.S. market. This shift is significant as it not only reflects the industry's adaptability but also highlights the importance of the U.S. as a key player in the global pharmaceutical landscape. By bolstering their operations in the U.S., these companies aim to mitigate potential impacts from tariffs, ensuring continued access to one of the largest healthcare markets in the world.
— Curated by the World Pulse Now AI Editorial System